FDA approves Johnson & Johnson’s ketamine-derived nasal spray for depression as standalone treatment
The announcement was welcome news for those with major depressive disorder, affecting an estimated 8.3% of the adult population.
Business
US Supreme Court leans toward reviving suit against Houston cop
By Andrew Chung (Reuters) -The U.S. Supreme Court appeared inclined on Wednesday to revive a...
Fed’s rate meeting next week likely to be a nothingburger as hold largely expected
Investing.com — The Federal Reserve is set for its first policy meeting next week, but...
CPI Aerostructures Stock Soars to 52-Week High of $5.27
CPI Aerostructures Inc . (NYSE:) stock has reached a remarkable 52-week high, touching $5.27, signaling...
easyJet cuts Q1 losses by 52% on festive demand and cost savings
Investing.com — easyJet’s (LON:) first-quarter result improved considerably, driven by strong holiday season demand and reduced...
ECB’s Knot is ‘comfortable’ with cuts at next two meetings – Bloomberg TV
FRANKFURT (Reuters) – European Central Bank policymaker Klaas Knot on Wednesday backed market bets on...
Pantheon Resources flags potential resource boost at Alaskan well
LONDON – Pantheon Resources PLC (AIM:PANR, OTCQX: PTHRF) has announced a potential increase in resource...
Hate needles? Lilly’s weight-loss pill could get FDA approval next year, CEO says
Compared to Lilly’s Zepbound (tirzepatide), the once-daily experimental drug would be simpler to produce.
Japan’s loneliness epidemic is so bad that elderly women are committing crimes to find friends and health care in prison
Japan’s largest women’s prison has become home to a growing number of seniors.
